Vein Treatment Center of NJ Paramus, NJ - 07652

Vein Treatment Center of NJ is categorized under Cardiologists in Paramus, NJ and active since 1987.

Vein Treatment Center of NJ was established in 1987, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Cardiologists business, which does work in the B2C market, and is classified as a Cardiologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact David Leibhauser, Office Manager at the company’s single location by writing to 1 West Ridgewood Avenue # 306, Paramus, New Jersey NJ 07652 or by phoning (201) 612-1750. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Vein Treatment Center of NJ
Contact Person: David Leibhauser, Office Manager
Address: 1 West Ridgewood Avenue # 306, Paramus, New Jersey 07652
Phone Number: (201) 612-1750
Annual Revenue (USD): $500.000 to $999.999
Founded: 1987
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Cardiologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Vein Treatment Center of NJ was started in 1987 to provide professional Cardiologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact David Leibhauser, Office Manager for inquiries that concern Vein Treatment Center of NJ by calling the company number (201) 612-1750, as your correspondence is most welcome. Additionally, the physical location of the single location of Vein Treatment Center of NJ can be found at the coordinates 40.969362,-74.081642 as well as the street address 1 West Ridgewood Avenue # 306 in Paramus, New Jersey 07652.

For its online presence, you may visit Vein Treatment Center of NJ’s website at and engage with its social media outlets through on Twitter and on Facebook.